U.S. Biotech Stock News

Corning stock has delivered a very large 3-year gain, yet its valuation checks are sending mixed signals, with a Discounted Cash Flow (DCF) estimate pointing to some upside while market multiples lean the other way. Over the past 3 years, Corning has returned about 3.9x, which puts extra focus on whether today’s price still leaves room for an attractive risk and reward trade off. Investor expectations around Corning’s role in AI related infrastructure and advanced glass products can support...

F.N.B. Corporation recently reported second-quarter 2026 results, with net interest income of US$365.72 million and net income of US$148.72 million, and also disclosed net loan charge-offs of US$17.0 million for the period. The company additionally updated its third-quarter and full-year 2026 earnings guidance, highlighting expectations for continued deposit competition while maintaining a clear outlook for both net interest and noninterest income. We’ll now examine how F.N.B.’s updated...

In July 2026, Halozyme Therapeutics announced a global collaboration and license agreement with Incyte to develop subcutaneous formulations of INCA033989, using Halozyme’s ENHANZE drug delivery technology to optimize dosing for patients with myeloproliferative neoplasms. This deal highlights Incyte’s push to pair its precision oncology pipeline with advanced delivery platforms, potentially broadening patient access and reinforcing its position in antibody-based therapies. We’ll now examine...

Coinbase Global’s share price has delivered a 62.3% gain over the past three years, but with the stock recently closing at US$160.43 and screening as overvalued on market multiples, the valuation now looks demanding rather than clearly cheap. Over the past three years, Coinbase Global has returned 62.3%, which puts recent weakness into context for longer term holders. Regulatory developments such as the advancing CLARITY Act and new UK approvals can support growth expectations, while softer...

Peoples Bancorp (PEBO) has drawn fresh attention after reporting mixed second quarter 2026 results, combining stronger revenue and net interest income with a GAAP earnings miss, alongside a newly affirmed quarterly cash dividend. See our latest analysis for Peoples Bancorp. Peoples Bancorp’s recent earnings and dividend announcement come as the stock shows firm momentum, with a 30.60% year to date share price return and a 76.57% five year total shareholder return. This suggests investors have...

Nvidia has disclosed a 9.3% passive stake in Nebius Group (NasdaqGS:NBIS). The holding formalizes a closer partnership between Nebius and Nvidia around AI infrastructure. The stake positions Nebius as a key participant in Nvidia’s broader AI ecosystem. Nebius Group sits at the intersection of cloud services and AI infrastructure, an area that continues to attract attention as demand for compute capacity, data processing, and model deployment tools grows. Nvidia’s 9.3% passive stake does not...

Aehr Test Systems (AEHR) is back on many investors’ radars after its latest earnings release, which paired improved fourth quarter profitability with management commentary for fiscal 2027 that highlighted record bookings, a strong backlog, and firm semiconductor testing demand. See our latest analysis for Aehr Test Systems. That upbeat fiscal 2027 commentary has come after a volatile stretch for Aehr Test Systems, with the stock falling about 33% on a 1 month share price return but still...

Enphase Energy (ENPH) stock has been under pressure after a series of earnings estimate cuts and a sharply lower sales outlook, as investors look ahead to the company’s July 28 earnings release. See our latest analysis for Enphase Energy. At a share price of $39.46, Enphase Energy has seen its short-term momentum fade, with a 1-day share price return down 5.08%, a 7-day return down 8.36%, and a 30-day return down 24.52%. This comes despite a 90-day share price return up 17.37% and a...

CVS Health (CVS) stock is in focus after the company opened its first pharmacy-focused CVS Pharmacy in Houston, part of a broader rollout of nearly 20 smaller, community-oriented locations nationwide. See our latest analysis for CVS Health. For investors tracking CVS Health, the recent pharmacy-focused expansion comes on top of strong momentum, with a 30-day share price return of 9.45%, a 90-day share price return of 39.10%, and a 1-year total shareholder return of 80.96%. This suggests that...

Investor interest in Zeta Global Holdings (ZETA) is being driven by its record of 19 consecutive quarters of outperforming internal guidance, a recent upward revision to full-year revenue and EBITDA outlook, and its AI-focused partnership with Palantir. See our latest analysis for Zeta Global Holdings. At a latest share price of $21.34, Zeta Global Holdings has seen short term share price weakness with a 7 day share price return of 2.42% decline. However, a 90 day share price return of 19.82%...

SpaceX’s first earnings report, large insider unlocks, and a heavily shorted stock set up a potential volatility shock that does not stay neatly contained to one ticker. When 911.5 million shares can suddenly hit the market, and more may follow if price targets are met, investors in aerospace, defense, and cloud companies with close ties to SpaceX’s world feel the ripple effects. This article breaks down 3 stocks that could be negatively exposed to these catalysts. It is intended to help you...

Advanced Micro Devices has delivered a very strong 5 year run, yet its current valuation signals are pulling in different directions, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium while market based multiples still suggest the stock may not be priced as richly. AMD has returned about 4.5x over 5 years, which sets a high bar for any further upside to be justified by fundamentals. Expectations tied to AI server demand and AI infrastructure partnerships can support...

Varonis Systems (VRNS) expanded its Varonis Atlas AI security platform to cover Anthropic’s full Claude enterprise suite, including Claude Code and Claude Cowork, alongside fresh support for the Cursor AI-native coding tool. See our latest analysis for Varonis Systems. Recent product news around Varonis Systems’ AI security coverage comes as the stock trades at $47.45, with a 30-day share price return of 42.15% and a 90-day share price return of 92.96%, while the 1-year total shareholder...

Planet Labs PBC recently launched Pelican-11, a Gen 2 tech demonstration satellite on SpaceX’s Transporter-17 mission from Vandenberg, beginning on-orbit testing to validate higher-resolution, AI-focused imaging technologies that are not intended for commercial data use. In parallel, Planet Labs UK has opened a central London office as a hub for AI and analytics partnerships with UK government and NATO stakeholders, signaling a deeper commitment to the UK space and defence ecosystem. Next,...

Meta Platforms faces a trial in Tennessee over claims that Instagram was intentionally designed to be addictive for young users. Plaintiffs also allege Meta concealed internal research about the app's effects on teen mental health and well-being. The case puts Meta's product design, user safety practices, and internal disclosures under legal and public scrutiny. For investors tracking Meta Platforms (NasdaqGS:META), this trial adds a fresh governance and regulatory angle to a story often...

GTT Communications and Hewlett Packard Enterprise (NYSE:HPE) have expanded their global partnership to offer new managed cloud networking and security services. The collaboration introduces services such as secure access service edge (SASE) and managed LAN/WLAN, using HPE Aruba Central and HPE Aruba Secure Connect. The new services target global enterprises looking to combine cloud based security with centralized network management. For investors watching Hewlett Packard Enterprise, this...

Agnico Eagle Mines stock has pulled back sharply in recent weeks, yet multiple valuation checks still point to it trading below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and on earnings multiples. For investors, that gap between price weakness and supportive valuation signals is what now stands out around Agnico Eagle Mines. Over the past 3 years, Agnico Eagle Mines has returned 178.6%, which puts the recent share price decline in the context of a strong...

CareDx (CDNA) is back in focus after Medicare finalized a Local Coverage Determination that confirms reimbursement for its molecular transplant surveillance tests across kidney, heart, and lung, with defined test limits by organ and by year. See our latest analysis for CareDx. The LCD decision comes after a sharp share price move, with CareDx’s 7 day share price return of 33.41% and 90 day share price return of 85.09% contributing to a 1 year total shareholder return of 200.94%, although the...

In mid-July 2026, Calix, Inc. reported second-quarter earnings and revenue that surpassed consensus estimates, while broadband cooperatives and fiber providers such as Consolidated Business Services, Tombigbee Fiber, and Garden Valley Technologies expanded adoption of its AI-native Calix One platform and Calix Agent Workforce Cloud. This combination of better-than-expected quarterly results and deeper integration of agentic AI across marketing, support, and operations underscores Calix’s...

Verizon Communications (VZ) is back in focus after unveiling a fresh restructuring step: selling 274 corporate-owned stores and cutting 500 office jobs, while investors also look ahead to its upcoming Q2 2026 earnings release. See our latest analysis for Verizon Communications. At a share price of US$43.50, Verizon Communications has seen its 7.35% year to date share price return and 9.37% one year total shareholder return supported by restructuring moves, new consumer products like Gizmo...

Tempus AI stock has fallen 22.4% year to date, yet the valuation checks point to a mixed picture rather than a clear verdict on whether the recent weakness leaves the shares cheap or still demanding. After declining 22.4% year to date, Tempus AI is back under pressure. This puts more focus on whether the current price fairly reflects its prospects in healthcare AI and diagnostics. The planned all stock acquisition of Personalis for about US$1.5b can support expectations of a larger role in...

Eaton (NYSE:ETN) has opened a European Aerospace Additive Manufacturing Center, focused on 3D printed components for aerospace applications. The new facility is intended to scale additive production, support regional aerospace demand, and strengthen supply chain resilience for next-generation platforms. Eaton is known for its power management and aerospace systems, and this new European additive manufacturing center adds another piece to its aerospace footprint. For investors watching the...

Realty Income (O) has recast and expanded its unsecured multicurrency revolving credit facilities to $5.5 billion, a financing move that matters for how the REIT funds acquisitions, refinancing needs, and day-to-day liquidity. See our latest analysis for Realty Income. Alongside this expanded credit capacity and recent euro bond issuance, Realty Income’s share price has gained 13.73% year to date, with a 30 day share price return of 8.20% and a 1 year total shareholder return of 21.99%. This...

Trip.com Group stock has delivered a 75.1% gain over the past 5 years, yet its valuation checks still suggest the shares screen as cheap rather than fully priced in. With the price recently at US$44.19 and sentiment shaped by both past returns and new partnerships, investors are weighing whether the current level leaves meaningful upside or already reflects the good news. A 75.1% return over 5 years points to a stock that has rewarded patient shareholders, while recent shorter term weakness...